Ignite Creation Date:
2025-12-24 @ 4:32 PM
Ignite Modification Date:
2026-02-01 @ 12:54 PM
Study NCT ID:
NCT05835466
Status:
RECRUITING
Last Update Posted:
2025-10-08
First Post:
2023-03-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
STUDY-22-01764
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |